Скачать или смотреть Optimize the preparation of your tumor samples for single-cell analysis of TILs [WEBINAR]

For more information, visit: https://www.miltenyibiotec.com/DE-en/... Single-cell analysis of tumors represents a powerful tool to characterize the tumor microenvironment. It is often applied to gain a better understanding of the anti-tumor immune response. The reliability and quality of any single-cell analysis experiment, such as single-cell sequencing, starts with proper sample preparation. For single-cell analysis of tumors, the main pre-requisite is to generate single-cell suspensions of high cell viability and free of debris. Then, specific cell types, e.g., TILs can be isolated. When working with snap-frozen tumors, nuclei are used as starting material since it is not feasible to retrieve viable cells. This webinar guides you through Miltenyi Biotec’s workflow optimized for the preparation of cells or nuclei from tumor samples. You will learn more about how gentle and automated technologies can help you achieve reliable and high-quality single-cell sequencing results.

The workflow covers sample storage, dissociation, clean-up, isolation, and quality control. All steps are optimized for and fully compatible with downstream single-cell analysis. They ensure fast and gentle processing to prepare the cells or nuclei prior your genomic analysis.

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.